Healthcare >> Analyst Interviews >> June 7, 2001
SUSHANT KUMAR, the newest Member Partner of Mehta Partners, has
extensive experience in technology assessment and market research from
Genesis Group Associates, where he was Senior Analyst and Consultant.
Earlier, Mr. Kumar was an American Cancer Society postdoctoral fellow at
Harvard Medical School, where he conducted research in viral oncology.
He has an extensive background in cancer research and has published
several articles in leading peer-reviewed journals. Mr. Kumar holds a
Doctorate in Molecular Biology from the University of Medicine and
Dentistry of New Jersey ' The Center for Advanced Biotechnology and
Medicine. Profile
TWST: Give us a review of the new technology environment that has fueledthe biotech wave, say, of the last five years.
Mr. Kumar: If you are going back five years, the key platform that